StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Caplin Point Laboratories Limited
NSE:CAPLIPOINT.NS
Sector
Location
Market Cap
USD 1.84 B
Share Price
USD 23.74
Avg Daily Volume
135,219
Change (1 day)
0.40%
Change (1 year)
30.57%
Change (YTD)
-18.75%
Caplin Point Laboratories Limited EBITDA Margin for the year ending March 31, 2025: 33.39%
Caplin Point Laboratories Limited EBITDA Margin is 33.39% for the year ending March 31, 2025, a -9.46% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Caplin Point Laboratories Limited EBITDA Margin for the year ending March 31, 2024 was 36.88%, a 8.83% change year over year.
-
Caplin Point Laboratories Limited EBITDA Margin for the year ending March 31, 2023 was 33.89%, a -1.25% change year over year.
-
Caplin Point Laboratories Limited EBITDA Margin for the year ending March 31, 2022 was 34.32%, a 2.14% change year over year.
-
Caplin Point Laboratories Limited EBITDA Margin for the year ending March 31, 2021 was 33.60%, a -4.06% change year over year.
Competitors
Johnson & Johnson
USD 156.82
JNJ
-0.08
-0.05%
Divi's Laboratories Limited
USD 78.93
DIVISLAB.NS
+0.11
0.14%
ALK-Abelló A/S
USD 30.67
ALK-B.CO
+0.26
0.84%
Nahdi Medical Company
USD 34.66
4164.SR
+0.27
0.77%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.08
-0.58%
Hypera S.A.
USD 4.80
HYPE3.SA
-0.05
-0.94%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.00
JBCHEPHARM.NS
-0.05
-0.26%
Almirall, S.A.
USD 12.85
ALM.MC
+0.07
0.52%
Organon & Co.
USD 9.81
OGN
-0.13
-1.31%
Dermapharm Holding SE
USD 40.18
DMP.DE
+0.15
0.38%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Johnson & Johnson
USD 156.82
JNJ
-0.08
-0.05%
Divi's Laboratories Limited
USD 78.93
DIVISLAB.NS
+0.11
0.14%
ALK-Abelló A/S
USD 30.67
ALK-B.CO
+0.26
0.84%
Nahdi Medical Company
USD 34.66
4164.SR
+0.27
0.77%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.08
-0.58%
Hypera S.A.
USD 4.80
HYPE3.SA
-0.05
-0.94%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.00
JBCHEPHARM.NS
-0.05
-0.26%
Almirall, S.A.
USD 12.85
ALM.MC
+0.07
0.52%
Organon & Co.
USD 9.81
OGN
-0.13
-1.31%
Dermapharm Holding SE
USD 40.18
DMP.DE
+0.15
0.38%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%